|4Feb 8, 5:27 PM ET

ALTSCHULLER Susan 4

4 · ImmunoGen, Inc. · Filed Feb 8, 2022

Insider Transaction Report

Form 4
Period: 2022-02-04
Transactions
  • Award

    Common Stock (right to buy)

    2022-02-04$5.32/sh+361,568$1,923,542361,568 total
    Exercise: $5.32From: 2023-02-04Exp: 2032-02-04Common Stock (361,568 underlying)
Footnotes (1)
  • [F1]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -